Filing Flows › Rapid Micro Biosystems (RPID) › Q4 2024
Rapid Micro Biosystems (RPID) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Feb 28, 2025
Rapid Micro Biosystems (RPID) reported revenue of $8.2M for the fourth quarter 2024 (Q4 2024), +30% from a year earlier and +8% from the quarter before. Operating margin was -124.5%, net loss $9.7M (117.6% of revenue).
Rapid Micro Biosystems, Q4 2024: revenue $8.2M (+30% year over year), operating margin -124.5%, net loss $9.7M, operating cash flow −$9.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.2M | +8% | +30% |
| Operating profit | −$10.2M | — | — |
| Net earnings | −$9.7M | — | — |
| Operating cash flow | −$9.9M | — | — |
What changed
Revenue was $8.2M in Q4 2024, up 30% year over year and up 8% from the previous quarter. Product was the largest line at 64% of revenue.
Operating costs exceeded revenue by $10.2M, an operating margin of -124.5%. Total costs fell 0% while revenue rose 30%. The fastest-growing cost line was Other operating costs (+11%). The quarter ended with a net loss of $9.7M, narrower than the previous quarter's $11.3M loss.
Operating cash flow was −$9.9M. Non-cash charges added back $869K of depreciation and amortization and $689K of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of $98K exceeded it, leaving free cash flow of −$10.0M.
Questions
What was Rapid Micro Biosystems' revenue in the fourth quarter 2024?
Rapid Micro Biosystems (RPID) reported revenue of $8.2M for the fourth quarter 2024 (Q4 2024), +30% from a year earlier and +8% from the quarter before.
Was Rapid Micro Biosystems profitable in the fourth quarter 2024?
Operating loss was $10.2M (-124.5% of revenue) and net loss $9.7M.